Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think that’s investor’s time zone. I hope to hear his impressions first!
Who is up at 4 am EST to observe the workshop tomorrow?
Dosage not age*
Yes, but what dosage(s) are the patients given? Thank you
What does age was the Retts trail OLE set at?
Thanks for the transcript, George!
Of course Q2 was a data rich quarter but I also recall TGD stating that Q4 would be a catalyst rich quarter. Am I misremembering /making that up? Does anyone recall the source?
New recruitment at site in Canada, this is a Twitter account in the province of Ontario. The recruitment is in British Columbia
Anavex Life Sciences has just announced they are recruiting patients for their study of ANAVEX2-73 in Rett syndrome patients at British Columbia Children’s Hospital in Vancouver. The study is the first ever clinical trial for Rett syndrome in the Canada!https://t.co/aeXkr6I86p pic.twitter.com/q2WraVa0sS
— O. R. S. A. (@OntarioRettSA) September 29, 2021
Yes, a Friday release is not a good omen. Could this have been something done earlier in the week and only registered now?
AD would be a great candidate for transfer in that case! Thanks
Thanks, regarding BTD, what likelihood Retts and PDD are being considered? In The June PRs TGD did state that Anavex was in contact and discussions for further guidance. Is this alluding to trial guidance or something else perhaps?
Yes, thanks, that’s what I meant (voucher not RPD). Can the voucher be transferred to any disease, AD for example or must it be a rare indication? Could 2-73 be granted BTD for Retts and or PDD? If so any thoughts on timeline?
Voucher that is…
Time to use or lose the RPD? Seems to late to transfer it.
I am always interested, especially in what you have to say
Now that is some positivity! Godspeed
Not obvious to all , Dyp. I need to get a copy of that text book
Nothing do to with a lawsuit or questionable data….
Not a certain lawsuit?
I don’t see a fire?!
Perhaps the allusion was at the last quarterly call, I may be mistaken
Do you think the peer review release may coincide the the fall PD conference along with the promised data presentation TGD alluded to in June?
How long did the proving of the last trial’s data take? It would be nice to see if there is improvement in the time it takes to interpret as per your proposal!
Regarding the Preventative AD Phase 3 Study: what are some thoughts on what the study participants pre-requisites/profile will be/look like?
I am also curious about trial locations and recruitment, I assume an international study like the the current AD trial?
As per Attila’s post and their profile: they portray themselves as investors, not traders.
Are we certain the DTC position was sold?
I wouldn’t be terribly upset!
So sorry I gave that impression. Honestly, I was trying to make a joke about holding one’s breathe waiting for Anavex results! Truly, more of and issue with past missed deadlines rather than this quarter. Still unfunny none the less when i do see and know of all the suffering out there!
In hindsight, I wish my position was that big in 2015. I have average my cost up and down since then and am very happy to know that my avxl investment will help me and my family down the road. Stay safe and healthy, Jager, I appreciate your concern.
Been holding since July 2015 myself. Thank God for resuscitation!
I hate to wish time away but these results can’t come soon enough and hopefully approvals shortly thereafter.
Is Missling saving the biggest PR for last in this data rich quarter?
Is an after hours PR a possibility?
PR Thursday morning?
Collins is da bomb!